Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

⚠ Preprint — not yet peer-reviewed alzhub usefulness score 16 out of 100. Genetics

Topic: Risk, prevention and care in population studies

BACKGROUNDSubjective cognitive decline (SCD) may precede mild cognitive impairment (MCI), but not all individuals with SCD progress to MCI. Identifying which individuals are most likely to convert and over what time frame remains an important goal in Alzheimers disease research. MRI measures of white matter hyperintensity (WMH) burden and gray matter (GM) atrophy may improve prediction beyond demographic and cognitive predictors, but their incremental value across different time intervals has not been established. METHODSData were obtained from four longitudinal cohorts (ADNI, NACC, CIMA-Q, and PREVENT-AD). A total of 1,352 participants with SCD at baseline were included. Machine learning models (logistic regression, random forest, XGBoost) were used to predict conversion from SCD to MCI at 2 years, 3 years, 4 years, and 5-year horizons. Four feature sets were compared: base (age, sex, education, APOE4, hypertension), base and cognition (adding MoCA and Trail Making Test Part B), base and MRI (adding regional WMH and GM volumes), and combined (all features). RESULTSThe base and MRI set achieved the highest Area Under the Curve (AUC) at the 3-year (0.900), 4-year (0.879), and 5-year (0.923) horizons. The combined set achieved the highest AUC at the 2-year horizon only (0.884). MRI features produced larger AUC gains over the base model than cognitive features at the 3, 4, 5-year horizons. Parietal WMH was the most frequently selected MRI predictor. CONCLUSIONSMRI features, particularly regional WMH and GM volumes, provided greater predictive value than cognitive features at longer prediction horizons. A select number of regional MRI features predicted SCD to MCI conversion with high accuracy up to 5 years in advance.

Key findings

Why it matters

This study used machine learning on MRI and other data to predict which people with subjective cognitive decline will develop mild cognitive impairment. MRI features, especially regional white matter hyperintensity and gray matter volumes, improved prediction more than cognitive tests at 3, 4, and 5 years, but this is a prediction tool, not a treatment or cure.

Study details

How this study scored 16/100
How this study's score is builtJournal tier 2 of 10; Journal's citation record 0 of 4; Study design 7 of 12; Strength of evidence 3 of 5; Peer-review validation 4 of 10; How recent 5 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomised / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year left out, no data; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 1 of 4; Institution's track record 1 of 3; Multi-centre collaboration 1 of 3; Indexed in PubMed 1 of 2; Free to read 2 of 2. 33 of the 94 points it could be judged on, which is 35 of 100. Raw total 35 of 100, shown as 16 because this is not a peer-reviewed research article.raw total 35 of 100capped at 16 — hatched points do not count

Preprint — not yet peer-reviewed. It scored 35 on the same rubric, but non-peer-reviewed sources are capped at 16, so it shows as 16. Scored zero for effect reported and randomised / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 33 of the 94 points we could judge it on, which is 35 out of 100.

ComponentPointsWhy
Journal tier 2 / 10 Tier 4 — not a peer-reviewed journal (medRxiv (preprint))
Journal's citation record 0 / 4 Not a journal article, so the journal's record does not count
Study design 7 / 12 A longitudinal study following the same people over time
Strength of evidence 3 / 5 Rated “moderate” in our summary
Peer-review validation 4 / 10 Preprint — not yet peer-reviewed. Hosted on a preprint server.
How recent 5 / 5 2026 — within 1 year(s) of the newest study here
Sample size 3 / 4 1,352 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomised / blinded 0 / 2 No randomisation or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 2 year(s) since 2026
Impact for its field and year — / 6 No field-weighted citation impact (OpenAlex has none yet) — left out of this score
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 1 / 4 Last-listed author Alzheimer’s Disease Neuroimaging Initiative: h-index 18 (OpenAlex, whole career)
Institution's track record 1 / 3 McGill University: institution h-index 1,373 (OpenAlex)
Multi-centre collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 1 / 2 Not in PubMed, but has a DOI
Free to read 2 / 2 Free to read
Points 33 / 94 Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 33 of the 94 points we could judge it on is 35 out of 100.
Total 35 / 100 Capped to 16 because this is not a peer-reviewed article.

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.

APA 7th

Kamal, F., Metz, A., Chadwick, K., Moqadam, R., Morrison, C., & Dadar, M. (2026). Predicting Conversion from SCD to MCI: A Machine Learning Study. medRxiv (preprint). https://doi.org/10.64898/2026.09.04.26362240

Vancouver

Kamal F, Metz A, Chadwick K, Moqadam R, Morrison C, Dadar M. Predicting Conversion from SCD to MCI: A Machine Learning Study. medRxiv (preprint). 2026. doi:10.64898/2026.09.04.26362240.

BibTeX

@article{kamal2026-13d655ad,
  author  = {Kamal, F. and Metz, A. and Chadwick, K. and Moqadam, R. and Morrison, C. and Dadar, M.},
  title   = {{Predicting Conversion from SCD to MCI: A Machine Learning Study}},
  journal = {medRxiv (preprint)},
  year    = {2026},
  doi     = {10.64898/2026.09.04.26362240},
  url     = {https://doi.org/10.64898/2026.09.04.26362240}
}

Studies this one cites

Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 13.

Related studies in Genetics

Similar studies

More on Genetics

See all studies in Genetics →